OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
136
Results
Show all
Save search
Copy query
Show results for
Unknown
(105)
Genomics
(25)
Metabolomics
(3)
Models
(1)
Transcriptomics
(1)
Multiomics
(1)
Proteomics
(1)
Organisms
Homo sapiens
(25)
Mus musculus
(1)
Repository
EGA
(25)
MetaboLights
(3)
BioModels
(1)
biostudies-arrayexpress
(1)
MassIVE
(1)
Technology Type
Illumina 15K
(8)
Mass spectrometry
(3)
Affymetrix 6.0
(1)
Illumina 1.2M, Affymetrix 6.0
(1)
Instrument Platform
Direct infusion MS - negative
(2)
Direct infusion MS - positive
(2)
LTQ Orbitrap Elite
(1)
LTQ Orbitrap Velos
(1)
Liquid Chromatography MS - Positive (LC-MS (Positive))
(1)
Liquid Chromatography MS - negative - hilic
(1)
Liquid Chromatography MS - negative - reverse phase
(1)
Liquid Chromatography MS - positive - reverse phase
(1)
Publication Date
2024
(1)
2011
(1)
2016
(1)
2025
(1)
2021
(1)
2018
(1)
CHEBI ID
CHEBI:39420
(2)
CHEBI:42394
(2)
CHEBI:134231
(1)
CHEBI:145247
(1)
CHEBI:155822
(1)
CHEBI:15760
(1)
CHEBI:157865
(1)
CHEBI:15978
(1)
CHEBI:16113
(1)
CHEBI:16196
(1)
CHEBI:16543
(1)
CHEBI:165552
(1)
CHEBI:165598
(1)
CHEBI:17084
(1)
CHEBI:17148
(1)
CHEBI:17351
(1)
CHEBI:176392
(1)
CHEBI:177274
(1)
CHEBI:177532
(1)
CHEBI:17768
(1)
CHEBI:178200
(1)
CHEBI:178201
(1)
CHEBI:178202
(1)
CHEBI:178203
(1)
CHEBI:178204
(1)
CHEBI:178205
(1)
CHEBI:178206
(1)
CHEBI:178207
(1)
CHEBI:178208
(1)
CHEBI:178209
(1)
Metabolite Name
1-docosene
(1)
2-Tetradecanone
(1)
CE(16:1(9Z))
(1)
Cer(d18:0/18:0)
(1)
Cer(d18:1/24:1(15Z))
(1)
CerP(d18:1/22:0)|PC(P-16:0/P-16:0)
(1)
DG(16:0/0:0/20:2n6)
(1)
DG(16:1n7/0:0/20:2n6)
(1)
Erucic acid
(1)
Free cholesterol
(1)
Leukotriene E3
(1)
LysoPC(16:0)
(1)
LysoPC(22:1(13Z))
(1)
PC(14:0/22:1(13Z))
(1)
PC(14:0/22:5(7Z,10Z,13Z,16Z,19Z))
(1)
PC(16:1(9Z)/16:0)
(1)
PC(18:1(9Z)/16:0)
(1)
PC(20:0/14:0)
(1)
PS(20:4(5Z,8Z,11Z,14Z)/18:0)
(1)
Pentacosanoic acid
(1)
SM(d17:1/24:0)
(1)
SM(d18:0/16:1(9Z))
(1)
SM(d18:1/24:1(15Z))
(1)
Tricosanoic acid
(1)
IsPrivate
False
(1)
Submitter Keywords
Machine Learning Model
(1)
Modelling Approach
Other
(1)
Study type
Transcription profiling by array
(1)
Release Date
2022
(17)
2024
(16)
2021
(16)
2023
(15)
2020
(8)
2019
(5)
2025
(4)
2013
(4)
2018
(3)
2017
(3)
2014
(3)
2011
(2)
2026
(2)
2016
(2)
2015
(2)
2012
(1)
2009
(1)
2007
(1)
2006
(1)
Previous
page
1 / 14
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
14
Next
page
Sort
by:
Relevance
Page size
10
Reduction in Renal Relapse and Preservation of Long-Term Kidney Function After Lupus Low Disease Activity in Patients With Lupus Nephritis.
Not available
S-EPMC12919694
|
biostudies-literature
Cite
Patient-centered approaches to targeting incomplete bowel preparations for inpatient colonoscopies.
Not available
S-EPMC8276365
|
biostudies-literature
Cite
Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.
Not available
S-EPMC3295555
|
biostudies-literature
Cite
Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor.
Not available
S-EPMC4881332
|
biostudies-literature
Cite
Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer.
Not available
S-EPMC6804854
|
biostudies-literature
Cite
Social branding to decrease smoking among young adults in bars.
Not available
S-EPMC4025707
|
biostudies-literature
Cite
Safety and efficacy of aerobic training in patients with cancer who have heart failure: an analysis of the HF-ACTION randomized trial.
Not available
S-EPMC4121507
|
biostudies-literature
Cite
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
Not available
S-EPMC5456373
|
biostudies-literature
Cite
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
Not available
S-EPMC6008104
|
biostudies-literature
Cite
Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report.
Not available
S-EPMC3739862
|
biostudies-literature
Cite
Previous
page
1 / 14
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
14
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
